Akanda Corp. (AKAN)
USD 1.08
(0.93%)
USD 1.08
(0.93%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 3.9 Million USD | 6.37% |
| 2022 | 3.67 Million USD | -39.54% |
| 2021 | 6.07 Million USD | -33.35% |
| 2020 | 9.1 Million USD | 0.0% |
| 2019 | - USD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q2 | -5.65 Million USD | 0.0% |
| 2023 Q2 | 4.74 Million USD | 4.99% |
| 2023 FY | 3.9 Million USD | 6.37% |
| 2023 Q3 | 3.78 Million USD | -20.29% |
| 2023 Q1 | 4.51 Million USD | 23.07% |
| 2023 Q4 | 3.9 Million USD | 3.29% |
| 2022 Q3 | 3.45 Million USD | 3634.99% |
| 2022 Q2 | -97.79 Thousand USD | 0.0% |
| 2022 Q1 | -97.79 Thousand USD | -101.61% |
| 2022 FY | 3.67 Million USD | -39.54% |
| 2022 Q4 | 3.67 Million USD | 6.19% |
| 2021 FY | 6.07 Million USD | -33.35% |
| 2021 Q1 | 13.5 Thousand USD | -99.85% |
| 2021 Q4 | 6.07 Million USD | 140.75% |
| 2021 Q3 | -14.89 Million USD | 0.0% |
| 2020 Q4 | 9.1 Million USD | 0.0% |
| 2020 FY | 9.1 Million USD | 0.0% |
| 2019 FY | - USD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Bright Green Corporation | 1.84 Million USD | -112.025% |
| Alpha Teknova, Inc. | 1.97 Million USD | -97.817% |
| ANI Pharmaceuticals, Inc. | 94.2 Million USD | 95.855% |
| Aquestive Therapeutics, Inc. | 74.95 Million USD | 94.79% |
| Collegium Pharmaceutical, Inc. | 435.33 Million USD | 99.103% |
| Cosmos Health Inc. | 8.59 Million USD | 54.545% |
| Journey Medical Corporation | -9.7 Million USD | 140.22% |
| Embecta Corp. | 1.31 Billion USD | 99.702% |
| Esperion Therapeutics, Inc. | 458.69 Million USD | 99.149% |
| Dynavax Technologies Corporation | 106.63 Million USD | 96.338% |
| Intra-Cellular Therapies, Inc. | -130.82 Million USD | 102.985% |
| Pacira BioSciences, Inc. | 432.74 Million USD | 99.098% |
| PainReform Ltd. | -7.95 Million USD | 149.118% |
| Sunshine Biopharma, Inc. | -15.63 Million USD | 124.976% |
| Sunshine Biopharma, Inc. | -15.63 Million USD | 124.976% |
| SCYNEXIS, Inc. | -19.35 Million USD | 120.18% |
| Safety Shot Inc | -2.28 Million USD | 270.94% |
| China SXT Pharmaceuticals, Inc. | -9.42 Million USD | 141.411% |
| Procaps Group, S.A. | 242.93 Million USD | 98.393% |
| Theratechnologies Inc. | 24.87 Million USD | 84.299% |
| Harrow Health, Inc. | 116.41 Million USD | 96.646% |
| Sonoma Pharmaceuticals, Inc. | -2.52 Million USD | 254.957% |
| Biofrontera Inc. | 4.05 Million USD | 3.725% |
| DURECT Corporation | -7.65 Million USD | 151.018% |
| Supernus Pharmaceuticals, Inc. | -33.52 Million USD | 111.647% |
| Cronos Group Inc. | -663.32 Million USD | 100.589% |
| OptiNose, Inc. | 58.06 Million USD | 93.275% |
| Ironwood Pharmaceuticals, Inc. | 623.38 Million USD | 99.374% |
| Kala Pharmaceuticals, Inc. | -14.57 Million USD | 126.797% |
| RedHill Biopharma Ltd. | -5.18 Million USD | 175.297% |
| Organogenesis Holdings Inc. | 15.01 Million USD | 73.99% |
| Guardion Health Sciences, Inc. | -6.35 Million USD | 161.401% |
| Cumberland Pharmaceuticals Inc. | 106.85 Thousand USD | -3554.27% |
| Radius Health, Inc. | 359.28 Million USD | 98.913% |
| Universe Pharmaceuticals INC | 197.2 Thousand USD | -1880.09% |
| ProPhase Labs, Inc. | 19.23 Million USD | 79.695% |
| Phibro Animal Health Corporation | 454.84 Million USD | 99.141% |
| Procaps Group S.A. | 242.93 Million USD | 98.393% |
| Alvotech | 1.06 Billion USD | 99.633% |
| TherapeuticsMD, Inc. | 3.67 Million USD | -6.17% |
| Viatris Inc. | 17.13 Billion USD | 99.977% |
| Rockwell Medical, Inc. | 4.45 Million USD | 12.367% |
| Aytu BioPharma, Inc. | -4.87 Million USD | 180.068% |
| SIGA Technologies, Inc. | -148.68 Million USD | 102.626% |
| Tilray Brands, Inc. | 158.97 Million USD | 97.544% |
| Lifecore Biomedical, Inc. | 121.89 Million USD | 96.797% |
| Shineco, Inc. | 29.29 Million USD | 86.668% |
| PetIQ, Inc. | 351.93 Million USD | 98.89% |
| Regencell Bioscience Holdings Limited | -2.9 Million USD | 234.586% |
| Incannex Healthcare Limited | -5.48 Million USD | 171.193% |
| Neurocrine Biosciences, Inc. | 177.3 Million USD | 97.798% |
| Alimera Sciences, Inc. | 55.3 Million USD | 92.94% |
| Silver Spike Investment Corp. | -32.61 Million USD | 111.974% |
| Assertio Holdings, Inc. | -32.52 Million USD | 112.004% |
| Shuttle Pharmaceuticals Holdings, Inc. | -1.48 Million USD | 362.3% |
| Petros Pharmaceuticals, Inc. | -5.06 Million USD | 177.166% |
| Clever Leaves Holdings Inc. | -4.81 Million USD | 181.116% |
| Cyclo Therapeutics, Inc. | -8.21 Million USD | 147.543% |
| Avadel Pharmaceuticals plc | 4.21 Million USD | 7.401% |
| Hempacco Co., Inc. | 13.61 Million USD | 71.318% |
| Talphera, Inc. | -5.72 Million USD | 168.256% |
| Alvotech | 1.06 Billion USD | 99.633% |
| Eagle Pharmaceuticals, Inc. | 7.14 Million USD | 45.348% |
| Lantheus Holdings, Inc. | -96.71 Million USD | 104.038% |
| Currenc Group, Inc. | -16.57 Million USD | 123.562% |
| Kamada Ltd. | -46.43 Million USD | 108.41% |
| Indivior PLC | -33.95 Million USD | 111.501% |
| Evoke Pharma, Inc. | 260.57 Thousand USD | -1398.582% |
| Flora Growth Corp. | -713 Thousand USD | 647.674% |
| Cyclo Therapeutics, Inc. | -8.21 Million USD | 147.543% |
| Evolus, Inc. | 63.7 Million USD | 93.871% |
| HUTCHMED (China) Limited | -197.45 Million USD | 101.978% |
| Amphastar Pharmaceuticals, Inc. | 479.11 Million USD | 99.185% |